(Q34419623)

2 August 2017

1 reference

title

The role of atypical pathogens in community-acquired pneumonia (English)

1 reference

2 August 2017

1 reference

Gupta SK

1

1 reference

2 August 2017

Sarosi GA

series ordinal

2

1 reference

2 August 2017

language of work or name

1 reference

1 November 2001

1 reference

Medical Clinics of North America

2 August 2017

published in

1 reference

2 August 2017

volume

85

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

1349-65, vii

1 reference

Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Microbial etiology of acute pneumonia in hospitalized patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Geographical variation of Legionnaires' disease: a critique and guide to future research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Aetiology of community acquired pneumonia in Valencia, Spain: a multicentre prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Incidence of community-acquired pneumonia caused by Chlamydia pneumoniae in Italian patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Rapid diagnosis of respiratory Chlamydia pneumoniae infection by nested touchdown polymerase chain reaction compared with culture and antigen detection by EIA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Efficacy of clarithromycin against Mycoplasma pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Growth on artificial medium of an agent associated with atypical pneumonia and its identification as a PPLO.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Viral pneumonias. Infection in the immunocompromised host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Mycoplasma pneumoniae as a cofactor in severe respiratory infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Acute community-acquired pneumonia due to Aspergillus in presumably immunocompetent hosts: clues for recognition of a rare but fatal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Fatal Nosocomial Legionnaires' Disease: Clinical and Epidemiologic Characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Severe community-acquired pneumonia: a possible role for Chlamydia pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Chlamydia pneumoniae pneumonia in hospitalized patients. Clinical characteristics and diagnostic value of polymerase chain reaction detection in BAL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

STUDIES ON THE ETIOLOGY OF PRIMARY ATYPICAL PNEUMONIA : A FILTERABLE AGENT TRANSMISSIBLE TO COTTON RATS, HAMSTERS, AND CHICK EMBRYOS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

7 January 2021

Legionella pneumophila

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features. British Thoracic Society Pneumonia Research Subcommittee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Legionnaires' disease: description of an epidemic of pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Fungal pneumonias. The endemic mycoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Delay in appropriate therapy of Legionella pneumonia associated with increased mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Evaluation of the Winthrop-University Hospital criteria to identify Legionella pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M. pneumoniae in acute respiratory tract infections in pediatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

7 January 2021

Eaton agent pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Rapid Radioimmunoassay Diagnosis of Legionnaires' Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Chlamydia pneumoniae community-acquired pneumonia: a review of 62 hospitalized adult patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Pneumonia with serological evidence of acute infection with the Chlamydia-like microorganism "Z".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Legionella species community-acquired pneumonia. A review of 56 hospitalized adult patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Mycoplasma pneumoniae community-acquired pneumonia: a review of 101 hospitalized adult patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Studies on primary atypical pneumonia. I. Localization, isolation, and cultivation of a virus in chick embryos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Effect of an organic gold salt on Eaton's primary atypical pneumonia agent and other observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Severe Community-Acquired Pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Community-acquired pneumonia: impact of immune status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Use of the polymerase chain reaction to detect Legionella DNA in urine and serum samples from patients with pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Community acquired pneumonia: aetiology and usefulness of severity criteria on admission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. Nordic Atypical Pneumonia Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Etiology of community-acquired pneumonia. Evaluation by transtracheal aspiration, blood culture, or serology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Severe community-acquired pneumonia. Etiology, prognosis, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Comparison of two serological methods and a polymerase chain reaction-enzyme immunoassay for the diagnosis of acute respiratory infections with Chlamydia pneumoniae in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

The epidemiology of community-acquired pneumonia among hospitalized adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Etiology and Diagnosis of Pneumonia Requiring ICU Admission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Diagnosis of Legionella pneumophila, Mycoplasma pneumoniae, or Chlamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Community-acquired pneumonia in the elderly. Clinical and nutritional aspects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

The incidence of legionella pneumonia: a 1-year prospective study in a large community hospital.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

'Atypical pneumonia'. Why this term may be better left unsaid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

The laboratory evaluation of opportunistic pulmonary infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

The radiologic manifestations of Legionnaire's disease. The Ohio Community-Based Pneumonia Incidence Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Polymerase chain reaction evaluation for Mycoplasma pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Multiplex polymerase chain reaction for the simultaneous detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Chlamydia psittaci in respiratory samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Severe Community-acquired Pneumonia: Epidemiology and Prognostic Factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Streptococcus pneumoniae bacteremia in a community hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Legionnaires' Disease: Clinical Features of the Epidemic in Philadelphia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Detection of Legionella by PCR in respiratory specimens using a commercially available kit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumonias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Legionnaires' disease: a review of 79 community acquired cases in Nottingham

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

7 January 2021

Detection of Mycoplasma pneumoniae by using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

7 January 2021

Detection of Chlamydia pneumoniae by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

7 January 2021

Relationships Between Mycoplasma pneumoniae and Human Respiratory Epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

7 January 2021

Comparison of the Binax Legionella urinary antigen enzyme immunoassay (EIA) with the Biotest Legionella Urin antigen EIA for detection of Legionella antigen in both concentrated and nonconcentrated urine samples.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

7 January 2021

New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

7 January 2021

Rapid diagnosis of Legionella pneumophila serogroup 1 infection with the Binax enzyme immunoassay urinary antigen test

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

7 January 2021

Rapid detection of Legionella species in bronchoalveolar lavage fluids with the EnviroAmp Legionella PCR amplification and detection kit.

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970384-9

7 January 2021

10.1016/S0025-7125(05)70384-9

Identifiers

DOI

1 reference

2 August 2017

1 reference